
Safety Efforts in Pediatric Drug Development
by
Conor D. Byrne
No ratings yet
Children’s
Format
Hardcover
Pages
133
Language
Slovenian
Published
Jun 1, 2009
Publisher
Nova Science Pub Inc
Edition
1
ISBN-10
1607415658
ISBN-13
9781607415657
Description
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
Reviews
Reading Log
No reading logs found
Start tracking your reading progress to see logs here
Add Your First Reading LogNotes
Transaction Log
No transaction logs found
Start tracking your book transactions to see logs here
Add Your First Transaction Log